References
- Accuracy of the references is the responsibility of the authors.
- Johnson RA. Trends in dermatology: re-emergence of the infectious diseases. In: Sober AJ, Fitzpatrick TB, eds. Year book of dermatology 1991. St Louis: Mosby—Year Book, 1991: xxi–xiv
- Angeles AM. Fungal and mycobacterial skin infections. Clin Dermatol 1991: 9: 65–9
- Nance KV, Smith ML, Joshi VV. Cutaneous manifestations of acquired immunodeficiency syndrome in children. Int J Dermatol 1991: 30: 531–9
- Lipsky BA. Diabetic foot infections: pathophysiology, diagnosis, and treatment. Int J Dermatol 1991: 30: 560–2
- Feder HM, Abrahamian LM, Grant-Kels JM. Is penicillin still the drug of choice for non-bullous impetigo? Lancet 1991: 338: 803–5
- Brumfitt W, Hamilton-Miller J. Methicillin-resistant Staphylococcus aureus. N Engl J Med 1989: 320: 1188–96
- Parish LC, Witkowski JA. Systemic management of cutaneous infections. Am J Med 1991: 91(Suppl 6A): 106–10S
- Witkowski JA, Parish LC. Bacterial skin infections: management of common streptococcal and staphylococcal lesions. Postgrad Med 1982: 72(4): 166–78
- Chartier C, Grosshans E. Erysipelas. Int J Dermatol 1990: 29: 459–67
- Demidovich CW, Wittier RR, Ruff ME. Impetigo: current etiology and comparison of penicillin, erythromycin, and cephalexin therapies. Am J Dis Child 1990: 144: 1313–5
- Parish LC, Witkowski JA. The infected decubitus ulcer. Int J Dermatol 1989: 28: 643–7
- Kahn G. Bacteriology of the skin and usual bacterial infections. In: Ruiz-Maldonado R, Parish LC, Beare JM, eds. Textbook of pediatric dermatology. Philadelphia: Grune & Stratton, 1989: 399–422
- Maibach HI, Aly R. Skin microbiology: relevance to clinical infection. New York: Springer-Verlag, 1981: 1–354
- Duhring LA. A practical treatise on diseases of the skin. Philadelphia: JB Lippincott, 1882: 288–304
- Parish LC, Aten EM. Treatment of skin and skin structure infection: a comparative study of Augmentin and cefaclor. Cutis 1984: 34: 567–70
- Parish LC, Parks DB, Layne PP, et al. Ceftizoxime treatment of cutaneous and subcutaneous tissue infections. Clin Ther 1984: 6: 613–9
- Parish LC, Witkowski JA. The quinolones and dermatologic practice. Int J Dermatol 1986: 25: 351–6
- Parish LC, Witkowski JA, Snow R, et al. Cephalosporins in cutaneous infections: a prospective comparison of two dosage regimens of ceftazidime for therapy of skin and skin structure infections. Int J Dermatol 1986: 25: 258–65
- Parish LC, Cocchetto DM, Werner K, et al. Cefuroxime axetil in the treatment of cutaneous infections. Int J Dermatol 1987: 26: 389–93
- Parish LC, Asper R. Systemic treatment of cutaneous infections: a comparative study of ciprofloxacin and cefotaxime. Am J Med 1987: 82(Suppl 4A): 227–9
- Parish LC, Witkowski JA, Jungkind DL, et al. Treatment of cutaneous infections: worldwide experience with ciprofloxacin. Int J Dermatol 1988: 27: 131–3
- Parish LC, Jungkind DL. Systemic antimicrobial therapy in skin and skin structure infections: comparison of temafloxacin with ciprofloxacin. Am J Med 1991: 91(Suppl 6A): 115–9S
- Wilkinson RD, Carey WD. Topical mupirocin versus topical Neosporin in the treatment of cutaneous infection. Int J Dermatol 1988: 27: 514–5
- Witkowski JA, Parish LC. Topical metronidazole gel: the bacteriology of decubitus ulcers. Int J Dermatol 1991: 30: 660–1
- Dillon HC. Topical and systemic therapy for pyodermas. Int J Dermatol 1980: 19: 443–51